Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05290246 · ClinicalTrials.gov registry record · NA
TRE in Type 2 Diabetes (See Food Study 3)
A NA study of Type2diabetes, sponsored by University of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT05290246 is a NA study of Type2diabetes that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 115 participants, below the 488-participant average among 19 other Type2diabetes trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05290246, a NA study of Type2diabetes, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential burden on quality of life. In contrast to intentionally restricting calories, time restricted eating (TRE), presents a simplified view of eating focused on restricting the eating window, which allows ad libitum intake per a person's dietary preferences during a daily fixed eating window. This study proposes a 24 week feasibility study to test if TRE is a viable alternative to Caloric Restriction in improving glycemic measures while accounting for weight loss in overweight/obese patients \[BMI:25-45 kg/m2\] with metformin-only treated Type 2 diabetes.
Conditions Studied
Interventions
- BEHAVIORAL Time restricted eating
- BEHAVIORAL Caloric reduction
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2022-05-27 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05290246
The ClinicalTrials.gov registry entry for NCT05290246 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 488-participant average among 19 other Type2diabetes trials with a reported enrollment target (76% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type2diabetes appearing as the primary indexed condition, and to 2 interventions - of which Time restricted eating is the first listed.
NCT05290246 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05290246 about?
NCT05290246 is a clinical study titled "TRE in Type 2 Diabetes (See Food Study 3)". Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential bur...
What is the current status of trial NCT05290246?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 115 participants. The study started on 2022-05-27. Estimated completion is 2026-03-31.
What conditions does trial NCT05290246 study?
This clinical trial studies the following conditions: Type2diabetes.
What interventions are being tested in trial NCT05290246?
The interventions under investigation include: Time restricted eating (BEHAVIORAL), Caloric reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT05290246?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05290246 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type2diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITING · NA
-
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
RECRUITING · NA
-
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
RECRUITING · NA
-
Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes
RECRUITING · NA
-
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
RECRUITING · NA
-
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.